Best eQMS for scaling post-market teams

November 18, 2026 ░░░░░░

Best eQMS for scaling post-market teams

The quality system that carried a device through clearance is rarely the one that can carry it through its fifth year on the market. A small team can hold a validated spreadsheet library and a shared drive together through a single submission. But add a second product, a contract manufacturer, a notified body audit cycle, and several hundred complaints a year, and the same setup becomes nearly impossible for a quality team to handle.

Most medical device companies hit this wall somewhere between first commercial shipment and second product launch. At this point, the system still technically works. What changes is the cost of holding it together, and that cost lands on people rather than on the software line: a quality engineer who loses two days a month chasing training records, or a document control specialist whose job has become version reconciliation.

Replacing a quality system after launch is different than choosing one before launch. A pre-market team is building a record from nothing, and our guide to selecting an eQMS as a device manufacturer covers that evaluation. A post-market team is moving a live, inspected, legally required record from one system to another without breaking traceability, while complaints keep arriving. The criteria below are written for the second situation.

What changes once a device is commercialized

Three forces stack up after launch, and each one presses on a different part of the quality system.

Volume is the obvious one. Complaints, nonconformances, supplier deviations and change requests arrive continuously rather than in bursts tied to design milestones. Triage that depended on one person reading every email breaks down once the volume passes what one person can read, and the first thing to slip is the clock on complaint evaluation.

Linkage is the one that catches teams off guard. Post-market surveillance only has value when the pieces connect. A complaint has to reach complaint handling triage, trend analysis and, when the criteria are met, CAPA. From there it reaches the risk file and, often, a design change. In a disconnected system each of those handoffs is a human remembering to make it, and in an audit each one is a question.

Scrutiny is the third. The FDA's Quality Management System Regulation (QMSR) took effect Feb. 2, 2026, incorporating ISO 13485:2016 by reference and retiring the QSIT inspection technique. Inspections now follow ISO 13485 structure, and investigators arrive expecting records that connect. European notified bodies have asked for post-market evidence with that same expectation for years, so the shift lands hardest on teams whose compliance history is FDA-only. A commercialized device also attracts customer quality agreements, supplier audits and, for companies raising money or selling, diligence requests that reach straight into the quality record.

BONUS RESOURCE: Click here to download the eQMS Buyer's Guide and build the business case for replacing your current system.

How to evaluate an eQMS when you already have one

Seven questions separate a replacement that reduces load from one that moves the load somewhere else. Vendor feature grids converge, and nearly every platform below has document control, training, CAPA and audit management, so a side-by-side of those modules decides nothing. What decides a replacement project is how the software handles the transition and the operating cost that follows it, which is why all seven are worth working through before you sit through a demo. Write down your own answer to each one first.

What happens to the records you already have?

Every other question assumes your records made it into the new system intact, which is why this one goes first. Your current record set is not a pile of files. It holds approved documents carrying their original approval metadata, training records that point to specific document revisions, closed CAPAs with their effectiveness checks and the complaint trends behind them, and a change log an investigator is entitled to ask about.

Ask who maps the legacy document structure and how long that mapping takes. Do approved documents keep their original approval dates and signatories, or does everything land in the new system with a 2026 timestamp? Historical CAPAs and complaints are the next test: structured records you can still trend against, or PDF attachments hanging off a document library? Then there is the migration record itself, because an inspector who notices a 2023 signature living in a 2026 system will want the rationale and the verification evidence behind it.

Then ask the same questions about leaving. What does a full export look like, in what format, and does it require vendor involvement or a paid services engagement? Proprietary formats and disorganized exports are a documented switching barrier, and the time to find that out is before you sign rather than five years later. A vendor whose complete migration answer is a template and a services quote has told you where the work lands, so price that answer as internal headcount rather than as a line item.

How much validation work lands on your team, and how often?

Validation is where post-market replacements stall, usually several weeks after the contract is signed. Pre-validated configurations with vendor-supplied test evidence remove most of that work, but only while your intended use matches the vendor's stated intended use. Configure beyond it, integrate something the package does not cover, or use a module in a way the vendor did not test, and the validation for that delta is yours.

The question most evaluations skip is what happens at the next change. On heavily configurable platforms each customization carries its own re-validation obligation, which makes validation an operating cost that recurs every time the business changes rather than a one-time project cost. Request the validation package before you sign, read what it covers, then read what it excludes, and map your planned configuration against the gap.

Does the complaint-to-design chain hold without someone maintaining it?

Complaint to CAPA to risk to design change is the chain auditors pull on, and it is the chain disconnected systems break first. Some platforms hold it in the data model. Others hold it through configured relationships a system administrator built and maintains, which works until that administrator changes jobs and nobody remembers why two record types were linked.

Ask to see the chain built live in a sandbox, starting from a complaint, and count both the clicks and the fields someone types by hand. The harder version of the question comes after a design change: what automatically flags the risk file and the affected post-market records, and what depends on a person remembering? Push on whether the system detects a broken reference when a linked document is revised, or whether a stale link sits there looking valid. Under ISO 14971, a risk file that is not linked to the design record stops being current the moment the design changes.

How long does audit prep take when the auditor is already in the room?

The useful measure is not whether a platform has an audit module. It is how long it takes to produce a requested record set during the session itself. Teams on connected systems describe pulling a device history record, a training matrix or a full CAPA file while the auditor waits, rather than building packets for weeks beforehand. Hart Biologicals cut audit preparation from weeks to hours after consolidating onto a connected system.

Ask customers in your size range and your regulatory footprint what their last notified body audit looked like in practice. How many days of preparation went into it, and whether anyone worked a weekend. References give you the clean version, so push for specifics and ask what they would not buy again.

One objection is worth retiring early in the process. Investigators do not care which platform holds the record. They care that it is complete and that you can produce it while they wait, which means a vendor's name is not evidence and no inspector will treat it as such.

Who builds a report when the format changes?

Post-market obligations are reporting obligations. Complaint rates normalized to units shipped, nonconformance trends by supplier, CAPA aging, overdue training by role: all of it goes to management review and to notified bodies on a schedule, whether or not the system makes that easy.

If building a new report means a vendor services ticket, a configuration specialist or an analytics module sold in a higher tier, you have found a recurring cost that never appears in the subscription quote. If it takes a quality engineer and an afternoon, there is no recurring cost at all. Ask to see the reports a current customer runs for management review rather than the dashboard built for your demo.

What does the system cost to administer at your headcount?

Configurability has an owner. Some platforms assume a dedicated system administrator, or a standing relationship with an implementation partner who holds the configuration knowledge. For a 400-person manufacturer with a quality organization that assumption is reasonable and often preferable. For a 40-person company with two quality staff it is the entire cost of the product, paid in the time of the two people you most need doing quality work.

Ask how many full-time equivalents comparable customers spend on administration, and what happens when the person who configured the system leaves. A routine change is the clearest test. Adding a workflow step or a new document type should have a price in both hours and dollars, and if that work needs a specialist skill set you do not currently employ, the platform is not priced at its subscription.

Does the platform match your manufacturing footprint?

Device companies running several global manufacturing sites with deep enterprise resource planning (ERP) integration requirements need platforms built for that complexity, and should weight ERP connectors, multi-site governance and production record depth heavily. Companies running one or two sites plus contract manufacturers usually pay for that depth and use a fraction of it.

Settle which one you are before building the shortlist, because the answer changes who belongs on it. Scoring an enterprise manufacturing platform against a two-site company's requirements produces a high score for capabilities that company will never turn on, and you pay for that score over the next five years.

The eQMS platforms post-market teams evaluate

The list below reflects what commercial-stage device companies put on replacement shortlists. Each entry is written against the seven questions above rather than against a feature matrix, and a pattern runs through them: what makes a platform worth evaluating is usually what makes it expensive to own.

Greenlight Guru

Greenlight Guru is purpose-built for medical device companies rather than adapted from a general life sciences or multi-industry platform. ISO 13485 and QMSR alignment sits in the product rather than in work your team does, and complaints, nonconformance, CAPA, risk management under ISO 14971, design controls, supplier management, training and document control run as connected modules, which is what keeps the complaint-to-design chain current without an administrator maintaining the links by hand.

Three things matter more to a replacement buyer than to a greenfield one. Validation for intended use comes out of the box, which removes the separate validation project several alternatives require, and document migration support sits in the standard package rather than in a services quote. Implementation also runs in weeks, supported by more than 40 medtech-aligned client success staff, which shortens the stretch where you pay to run two systems at once.

MasterControl

MasterControl is one of the longest-established quality platforms in regulated manufacturing. Auditors recognize the name, its lot and batch controls hold up at manufacturing scale, and configuration can match almost any process a quality team has already written down.

Configuration is also where the money goes, and a team replacing a system to reduce load should look closely at that. The platform serves pharmaceutical, food, biologics and device customers from a common core, so device-specific structure is something you build rather than something you receive, and in a validated environment each build carries validation and re-validation work behind it. Two things to scope before you compare license costs: what updating the system for a regulatory change involves, since on a heavily configured platform that is an internal change-control project rather than a vendor update, and what a clean export looks like on the way out.

Veeva Vault QMS

For a company running both pharmaceutical and device divisions, Veeva makes an argument no device-only vendor can. Vault QMS handles large multi-site global operations, and the name carries weight with boards, investors and partners who already know it from the pharma side.

Pharma is also where the product's design assumptions come from. Medtech workflows sit on a platform shaped by pharmaceutical release and change patterns, and implementations run on enterprise timelines measured in quarters. Teams whose product includes software should confirm how the software lifecycle structure they need is handled. Most of the argument also depends on the surrounding Vault footprint, so a device company adopting Vault QMS on its own is paying for a platform advantage it does not yet have.

Qualio

Qualio is a clean, approachable life sciences eQMS with a short learning curve. Teams moving off paper or shared drives often pick it, which is why it turns up so frequently among the systems post-market teams are now replacing.

Serving pharma, biotech and devices from one product is Qualio's market, and two questions follow for a commercialized team. How much device-specific record structure arrives configured, and how much does your team build and validate? And how do design controls and risk connect to complaints, CAPA and trending, given that the linkage is what keeps traceability current as a product changes? Data extraction is worth asking about directly, since it determines what a future migration costs.

ETQ

ETQ is an established enterprise quality platform serving regulated manufacturing broadly, with the governance depth that implies and a customer base reaching well past medical devices. For a manufacturer running several product lines, or operating outside medtech as well as inside it, one quality platform instead of two removes a second contract and a second validation effort.

The evaluation question is a category one. How much of the ISO 13485 and QMSR structure you need arrives native, how much of it you configure, and what that configuration costs in validation effort over the life of the contract.

Arena

Arena came out of product lifecycle management and was acquired by PTC in 2021, and that origin explains most of what a buyer finds in it. If your central problem is connecting the product record to the quality record, Arena is one of the stronger answers available, with mature bills of materials, engineering change workflows and supplier collaboration.

The quality side grew out of the product side rather than beside it, and the platform serves electronics, aerospace and defense in addition to medical devices, so device compliance structure is work you take on. For a post-market team whose daily load is complaint intake, trending and surveillance rather than engineering change, the platform's strength sits on a part of the workload that is not the one hurting. Check tier detail as well, since supplier quality management and analytics capability can sit in a higher package than the standard QMS tier.

Dot Compliance

Dot Compliance is built natively on Salesforce and ships with pre-configured processes and its own AI tooling. An organization already standardized on Salesforce starts from a familiar place, since the administrators are already on staff and the learning curve is shorter for everyone outside the quality team.

Running your quality system on Salesforce also means paying for Salesforce alongside your QMS for as long as you run it, and leaning on Salesforce administration for configuration changes quality staff might otherwise own. For a team replacing a system specifically to reduce administrative work, that dependency is the line item to price. Model the full five-year picture rather than the first-year quote.

Making the switch

Score vendors against your own record set rather than a feature list. Pick three artifacts from your current system: a controlled document with a long and messy revision history, a closed CAPA, and the complaint that triggered it. Ask each vendor to show you those exact records living in their platform. Vendors who can do it in a sandbox during the evaluation are demonstrating the migration capability they are selling. Vendors who deflect to a services conversation are answering too.

Then talk to customers who switched rather than customers who started fresh, and ask what the first audit after migration looked like. Ask how long the legacy system stayed running in parallel, because the answer is almost never zero and you pay for both during the overlap. Ask what they would have scoped differently. Our guide to eQMS implementation covers what that transition period looks like in practice.

Most teams replacing a post-market quality system are not solving a software problem. They are paying for the gap between the system they launched on and the volume they now run, in hours spent reconciling records by hand and in traceability that holds only as long as someone remembers to maintain it. The system that removes the most of that at your headcount is the right answer, and every other capability is secondary.

BONUS RESOURCE: Click here to download the eQMS Buyer's Guide and the criteria to score your shortlist against.

If you want to see how a device-specific system handles the seven questions above, get a demo of Greenlight Guru and bring your messiest migration scenario with you.

Keep reading

Greenlight Guru is the leading cloud-based platform purpose-built for MedTech companies. The end-to-end solution streamlines product development, quality management, and clinical data management by integrating cross-functional teams, processes, and data throughout the entire product lifecycle. Greenlight Guru’s...

FREE eBOOK:
eQMS Buyer's Guide
Download Now
(cover) eQMS Buyer's Guide- Making the Business Case for a New QMS Solution
Search Results for:
    Load More Results